We tested this hypothesis by assessing behaviors associated with anxiety, depression, and motor function, as well as molecular and physiological properties of MSNs in mice with a selective knockout of Bmal1 and Per2 from striatal MSNs. This evidence concerns the gene BMAL1 and depressive symptom measurement.